• Search History (Register)
  • MeSH Browser
Sort by Relevance
Search Results [1526 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2013 Agency for Healthcare Research and Quality (AHRQ) Screening for lung cancer: systematic review to update the U.S. Preventive Services Task Force Recommendation
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Screening tools to identify adults with mild cognitive impairment not associated with dementia: a review of diagnostic accuracy, effectiveness and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Screening tools compared to parental concern for identifying speech and language delays in preschool children: a review of the diagnostic accuracy
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Screening and diagnostic tools for autism spectrum disorder in children: a review of guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Portable bone mineral density scanners for screening and diagnosis of osteoporosis: uses, limitations, and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Screening for sexually transmitted infections: a review of guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Prioritizing patients undergoing non-urgent, medically necessary cosmetic surgical procedures: clinical evidence and guidelines
2013 Institute for Clinical Effectiveness and Health Policy (IECS) [Preimplantation genetic screening (PGS) in patients undergoing high-complexity reproduction technologies]
2013 Institute for Clinical Effectiveness and Health Policy (IECS) [Digital tomosynthesis for the diagnosis of breast cancer]
2013 HAYES, Inc. Phenylalanine hydroxylase (PAH) deficiency (including phenylketonuria [PKU])
2013 HAYES, Inc. Prolaris test for prediction of prostate cancer progression
2013 NIHR Horizon Scanning Centre (NIHR HSC) SmartSensor electronic oral glucose tolerance test for screening for diabetes
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Diabetes screening for asymptomatic adults: a review of the diagnostic accuracy, cost effectiveness, and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Prostate cancer screening: a review of the guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Optimal screening procedures prior to physician visits: guidelines
2013 Health Council of the Netherlands Gezondheidsraad (GR) Population Screening Act: mammography in two directions as standard
2013 Health Council of the Netherlands Gezondheidsraad (GR) Population Screening Act: calcium score and the risk of cardiovascular disease
2013 Health Council of the Netherlands Gezondheidsraad (GR) Population Screening Act: national population screening programme for bowel cancer
2013 Health Council of the Netherlands Gezondheidsraad (GR) Population Screening Act: Continuing a population screening trial
2013 Health Council of the Netherlands Gezondheidsraad (GR) Population Screening Act: bowel cancer screening by pill camera
2013 Health Council of the Netherlands Gezondheidsraad (GR) NIPT: dynamics and ethics of prenatal screening
2013 Health Council of the Netherlands Gezondheidsraad (GR) Population Screening Act: noninvasive prenatal test for increased risk of trisomy
2013 Andalusian Health Technology Assessment Area (AETSA) [Effectiveness of computer-aided diagnosis applied to breast cancer screening. Systematic review]
2013 Andalusian Health Technology Assessment Area (AETSA) [Efficacy, effectivity and efficiency of liquid cytology for cervical cancer screening and HPV infection diagnosis]
2013 Health Quality Ontario (HQO) Role of screening for respiratory syncytial virus or influenza and empirical antiviral treatment for patients with community-acquired pneumonia: a rapid review
2013 Blue Cross Blue Shield Association (BCBS) Noninvasive prenatal cell-free fetal DNA-based screening for aneuploidies other than trisomy 21
2013 Medical Services Advisory Committee (MSAC) Cell enrichment liquid based cytology (LBC) in routine screening for the prevention of cervical cancer
2013 Malaysian Health Technology Assessment (MaHTAS) NH2 Drug Lab (DRUGKOP)
2013 Basque Office for Health Technology Assessment (OSTEBA) [Models of collaboration and intervention between primary care and mental health in the care of patients diagnosed with depression: results of a meta-review]
2013 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Assessment of the benefit of screening in persons under 55 years of age with a family history of colorectal cancer]
2013 Canary Health Service [Cost-effectiveness of neonatal screening for biotinidase deficiency]
2013 Canary Health Service [Cost-effectiveness of neonatal screening for congenital adrenal hyperplasia]
2013 Canary Health Service [Cost-effectiveness of neonatal screening for classical galactosemia]
2013 Canary Health Service [Cost-effectiveness of neonatal screening for tyrosemia type I]
2013 Canary Health Service [Cost-effectiveness of newborn screening for sickle cell anemia]
2012 NIHR Health Technology Assessment programme Pulse oximetry as a screening test for congenital heart defects in newborn infants: a test accuracy study with evaluation of acceptability and cost-effectiveness
2012 The Netherlands Organisation for Health Research and Development (ZonMw) [Implementation of screening and treatment of high-risk fracture patients by an osteoporosis nurse-practitioner]
2012 NIHR Health Technology Assessment programme Screening for cystic fibrosis-related diabetes: a systematic review
2012 Belgian Health Care Knowledge Centre (KCE) Hepatitis C screening and prevention
2012 NIHR Horizon Scanning Centre (NIHR HSC) HPV OncoTect® E6 E7 mRNA Assay to guide colposcopy referral in cervical cancer screening
2012 NIHR Horizon Scanning Centre (NIHR HSC) DELFIA® Xpress PlGF kit antenatal screening test to predict risk of pre-eclampsia
2012 HAYES, Inc. Screening, Brief Intervention, and Referral to Treatment (SBIRT) using remote interventions for alcohol misuse
2012 Penn Medicine Center for Evidence-based Practice (CEP) Screening tests for aspiration and dysphagia
2012 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Reorientation of the Austrian parent-child preventive care programme. Part V: Preterm birth]
2012 HAYES, Inc. Septin 9 (SEPT9) methylation analysis for colorectal cancer
2012 HAYES, Inc. Third eye retroscope (Avantis Medical Systems Inc.) for aiding the colonoscopic detection of colorectal polyps and adenomas
2012 Canadian Agency for Drugs and Technologies in Health (CADTH) Newborn screening for krabbe leukodystrophy: a review of the clinical and cost effectiveness and guidelines
2012 Canadian Agency for Drugs and Technologies in Health (CADTH) Newborn screening for cystic fibrosis: a review of the clinical and cost-effectiveness
2012 Institute of Health Economics (IHE) First and second trimester prenatal screening for trisomies 13, 18, and 21 and open neural tube defects
2012 Andalusian Health Technology Assessment Area (AETSA) [Efficacy and safety of genetic tests for screening of colorectal cancer]
2012 Institut national d'excellence en sante et en services sociaux (INESSS) [Immunochemical fecal occult blood. Determination of a positivity threshold for the upcoming demonstration projects under Québec's colorectal cancer screening program]
2012 Institut national d'excellence en sante et en services sociaux (INESSS) [Specialized services for people with alzheimer's disease]
2012 Agency for Healthcare Research and Quality (AHRQ) Screening and diagnosing gestational diabetes mellitus
2012 Agency for Healthcare Research and Quality (AHRQ) Multigene panels in prostate cancer risk assessment
2012 Agency for Healthcare Research and Quality (AHRQ) Diagnosis and management of febrile infants (0–3 months)
2012 NIHR Horizon Scanning Centre (NIHR HSC) SCOUT DS® and Diab-spot for type 2 diabetes screening
2012 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [HIV screening in the general population]
2012 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Screening for colorectal cancer part 1: screening-tests and program design
2012 Andalusian Health Technology Assessment Area (AETSA) [Extended neonatal screening for lysosomal diseases by mass spectrometry]
2012 Andalusian Health Technology Assessment Area (AETSA) [Rapid tests for methicillin resistant Staphylococcus aureus. Carrier screening. Executive summary]
2012 HAYES, Inc. Harmony™ Prenatal Test
2012 HAYES, Inc. Radioactive seed localization (RSL) of nonpalpable breast lesions for surgical excision
2012 Agency for Healthcare Research and Quality (AHRQ) Noninvasive diagnostic tests for breast abnormalities: update of a 2006 review
2012 Agency for Healthcare Research and Quality (AHRQ) Fecal DNA testing in screening for colorectal cancer in average-risk adults
2012 Agency for Healthcare Research and Quality (AHRQ) Screening for glaucoma: comparative effectiveness
2012 HAYES, Inc. Screening, brief intervention, and referral to treatment (SBIRT) for substance use among pregnant women
2012 HAYES, Inc. Breast-specific gamma imaging (BSGI) using the dilon 6800 gamma camera (Dilon Technologies Inc.)
2012 HAYES, Inc. EarlyCDT-lung risk assessment test (Oncimmune [USA] LLC)
2012 Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Economic evaluation of the introduction of the HPV vaccine in Spain to prevent cervical cancer]
2012 HAYES, Inc. Selenia dimensions digital tomosynthesis system (Hologic Inc.) for diagnostic mammography
2012 HAYES, Inc. Ki-67 (MKI67) proliferation marker testing in ductal carcinoma in situ (DCIS) and breast cancer
2012 Andalusian Health Technology Assessment Area (AETSA) [Heterochromatic flicker photometry for the detection of the risk of age-related macular degeneration]
2012 Andalusian Health Technology Assessment Area (AETSA) [Digital tomosynthesis of the breast]
2012 Penn Medicine Center for Evidence-based Practice (CEP) Guidelines for use of screening and preventive services
2012 Scottish Health Technologies Group (SHTG) What is the clinical and cost effectiveness of human papillomavirus (HPV) testing, followed by liquid-based cytology triage of positive results, in primary screening for cervical cancer?
2012 Scottish Health Technologies Group (SHTG) High-risk human papillomavirus (HPV) testing as triage for women with mild or borderline cytology abnormalities
2012 National Evidence-based Healthcare Collaborating Agency (NECA) [A research on evidence-based healthcare for thyroid cancer screening: Part 2: Effectiveness of ultrasonographic screening for thyroid cancer]
2012 National Evidence-based Healthcare Collaborating Agency (NECA) [A research on evidence-based healthcare for thyroid cancer screening: Part 1: the current status of thyroid cancer screening]
2012 Health Information and Quality Authority (HIQA) Economic evaluation of repeat universal antenatal screening for HIV in the third trimester of pregnancy
2012 Agency for Healthcare Research and Quality (AHRQ) Screening for HIV in pregnant women: systematic review to update the U.S. Preventive Services Task Force Recommendation.
2012 Agency for Healthcare Research and Quality (AHRQ) Screening for HIV: systematic review to update the U.S. Preventive Services Task Force Recommendation
2012 Agency for Healthcare Research and Quality (AHRQ) Screening women for intimate partner violence and elderly and vulnerable adults for abuse: systematic review to update the 2004 U.S. Preventive Services Task Force Recommendation.
2012 Agency for Healthcare Research and Quality (AHRQ) Screening for hepatitis C virus infection in adults
2012 Agency for Healthcare Research and Quality (AHRQ) Screening, behavioral counseling, and referral in primary care to reduce alcohol misuse
2012 Agency for Healthcare Research and Quality (AHRQ) Chronic kidney disease stages 1–3: screening, monitoring, and treatment.
2012 Institute for Clinical Effectiveness and Health Policy (IECS) [Photodynamic therapy for non-melanocytic skin cancer treatment]
2012 Institute for Clinical Effectiveness and Health Policy (IECS) [Combined screening for early diagnosis of chromosomal abnormalities during the first trimester of pregnancy]
2012 Institute for Clinical Effectiveness and Health Policy (IECS) [Catheter-directed mechanical thrombolysis in thromboembolic disease]
2012 Health Council of the Netherlands Gezondheidsraad (GR) Population Screening Act: accelerated repeat screening for bowel cancer
2012 Health Council of the Netherlands Gezondheidsraad (GR) Population Screening Act: tuberculosis screening
2012 Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Systematic Review of the efficacy, effectiveness, safety and cost of Preimplantational Genetic Screening]
2012 Institute of Health Economics (IHE) The effectiveness and safety of preschool hearing screening programs
2012 Institute of Health Economics (IHE) The safety and effectiveness of preschool vision screening
2012 Institute of Health Economics (IHE) The safety and efficacy/effectiveness of using automated testing devices for universal newborn hearing screening: an update
2012 HTA Unit, University of Calgary A health technology assessment of transient elastography in liver disease
2012 Malaysian Health Technology Assessment (MaHTAS) Point-Of-Care test for Chlamydia
2012 Basque Office for Health Technology Assessment (OSTEBA) [Evaluation of the implementation of clinical guidelines in the Basque Country. Cluster randomized trial]
2012 Basque Office for Health Technology Assessment (OSTEBA) [Seroprevalence of Trypanosoma Cruzi infection in Latin American women of fertile age and during pregnancy in the Autonomous Community of the Basque Country]
2012 Basque Office for Health Technology Assessment (OSTEBA) [Cost evaluation of the early breast cancer detection programme of the Autonomous Community of the Basque Country]
2012 Basque Office for Health Technology Assessment (OSTEBA) [Validation of a malnutrition screening tool useful in a general hospital]